MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 05-23-2026
Accelerate Diagnostics ROCE Ratio 2011-2026 | AXDX
Annual ROCE Ratio Accelerate Diagnostics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 63.01 | 271.66 | 282.09 | 55.35 | 101.41 | -57.68 | -45.28 | -54.06 | -84.38 | -33.99 | -47.02 | -36.17 | -21.2 | -6.61 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 282.09 | -84.38 | 27.65 |
Quarterly ROCE Ratio Accelerate Diagnostics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123.66 | 138.43 | 155.24 | 115.85 | 265.64 | 252.85 | 248.65 | 207.18 | 262.52 | 149.3 | 145.48 | 147.31 | 115.97 | 109.94 | 127.23 | 174.33 | 397.91 | 194.64 | 82.58 | -38.51 | -320.52 | -172.82 | -124.78 | -100.54 | -79.69 | -68.0 | -58.04 | -59.18 | -66.18 | -71.95 | -77.42 | -69.4 | -76.7 | -82.46 | -81.67 | -69.0 | -81.21 | -63.7 | -53.64 | -37.4 | -45.83 | -47.35 | -45.45 | -30.64 | -33.49 | -35.25 | -29.42 | -30.18 | -28.39 | -27.42 | -19.47 | -19.17 | -9.23 | 0.05 | -8.93 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 397.91 | -320.52 | 20.94 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | USA |
 |
Fulgent Genetics
FLGT
|
-8.19 | $ 19.5 | 7.5 % | $ 600 M | USA |
 |
Celcuity
CELC
|
-171.24 | $ 92.47 | 3.96 % | $ 4.32 B | USA |
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
-236.6 | $ 5.76 | 11.41 % | $ 7.66 M | USA |
 |
Guardant Health
GH
|
440.3 | $ 133.06 | 4.75 % | $ 16.7 B | USA |
 |
Castle Biosciences
CSTL
|
-9.09 | $ 21.6 | 5.93 % | $ 626 M | USA |
 |
Aspira Women's Health
AWH
|
114.15 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M |  Britain |
 |
CareDx, Inc
CDNA
|
-10.16 | $ 23.12 | 3.63 % | $ 1.23 B | USA |
 |
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | USA |
 |
ICON Public Limited Company
ICLR
|
4.82 | $ 152.8 | 6.18 % | $ 12 B |  Irlanda |
 |
Check-Cap Ltd.
CHEK
|
-69.04 | - | - | $ 9.42 M |  Israel |
 |
Interpace Biosciences
IDXG
|
18.26 | $ 1.79 | 2.29 % | $ 7.92 M | USA |
 |
Illumina
ILMN
|
29.64 | $ 168.06 | -1.68 % | $ 26 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | USA |
 |
Lantheus Holdings
LNTH
|
28.52 | $ 102.82 | 2.56 % | $ 6.94 B | USA |
 |
Charles River Laboratories International
CRL
|
0.8 | $ 185.79 | 3.29 % | $ 9.21 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | USA |
 |
Mettler-Toledo International
MTD
|
35.8 | $ 1 180.48 | 0.95 % | $ 24.3 B |  Schweiz |
 |
Medpace Holdings
MEDP
|
116.53 | $ 458.69 | 1.75 % | $ 13.2 B | USA |
 |
NeoGenomics
NEO
|
-9.11 | $ 11.31 | 11.54 % | $ 1.45 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.59 | - | - | $ 19.8 B | USA |
 |
Natera
NTRA
|
-18.1 | $ 222.1 | 4.84 % | $ 30.4 B | USA |
 |
National Research Corporation
NRC
|
161.47 | $ 19.75 | 3.73 % | $ 442 M | USA |
 |
Myriad Genetics
MYGN
|
-105.22 | $ 4.69 | 6.59 % | $ 434 M | USA |
 |
Personalis
PSNL
|
-33.71 | $ 12.1 | 12.24 % | $ 1.08 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
7.33 | $ 25.99 | 2.48 % | $ 24.6 B |  Niderland |
 |
Senseonics Holdings
SENS
|
-111.94 | $ 7.01 | 4.32 % | $ 293 M | USA |
 |
QIAGEN N.V.
QGEN
|
8.07 | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
2.09 | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
-125.14 | $ 2.15 | 1.9 % | $ 4.94 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
16.06 | $ 260.97 | 0.79 % | $ 21.7 B | USA |
 |
Twist Bioscience Corporation
TWST
|
-28.81 | $ 73.93 | 2.21 % | $ 4.42 B | USA |
 |
Thermo Fisher Scientific
TMO
|
14.5 | $ 482.03 | 1.7 % | $ 182 B | USA |
 |
Trinity Biotech plc
TRIB
|
-29.73 | $ 0.68 | -2.4 % | $ 244 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
-51.22 | $ 9.12 | 3.52 % | $ 1.98 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
21.7 | $ 196.12 | 1.27 % | $ 21.8 B | USA |
 |
Invitae Corporation
NVTA
|
-93.18 | - | - | $ 21.2 M | USA |
 |
Waters Corporation
WAT
|
7.05 | $ 376.47 | -0.87 % | $ 22.4 B | USA |